Answers are grounded in this paper and cite their sources.
Twenty-five cases of hyperbilirubinemia have been treated with parenteral sodium glucuronate, most of them being patients with hemolytic disease (erythroblastosis). The authors believe the results have been encouraging and warrant a further experimental trial of this form of therapy by critical investigators.
No takes yet. Share an insight, caveat, or question.
Danoff et al. (1959) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: